AB
Allison Bratzel Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
81.8%
Neutral
18.2%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $58 |
16%
upside
| 1 | +12% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $100 |
32%
upside
| 2 | +18% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $38 |
7%
downside
| 1 | – |
–
| 6 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $84 |
54%
upside
| 1 | +0.84% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $110 |
12%
upside
| 1 | -4.1% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $4 |
184%
upside
| 1 | +9.4% |
0
%
| 6 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $14 |
545%
upside
| 1 | -8.9% |
0
%
| 5 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $4 |
140%
upside
| 1 | +3.5% |
0
%
| 5 Feb ‘26 2 months ago |
|
|
|
Neutral
Downgraded
| $0.5000 |
942%
upside
| 1 | -64% |
0
%
| 26 Jan ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $42 |
18%
upside
| 1 | +115% |
0
%
| 23 Jan ‘26 2 months ago |
|